NanoLogix, Inc. is pleased to
announce that major advances have been made in the rapid detection of
Anthrax utilizing the NanoLogix BioNanoChannel Device.
here appears to be an opportunity to determine the viability
and persistence of Anthrax spores much faster than current methods due
to the unique rapid culturing aspects of the BNC technology. "Superb
progress has been made in our research efforts simulating Anthrax spore
growth through the use of non-hazardous spores. This research has the
potential to immediately translate to the ability to conduct rapid
Anthrax viability testing," said CEO Bret Barnhizer. "We have been
impressed with the Department of Defense's dedication to finding the
best solution for the security of our country in the event of a
biological attack. We look forward to making a major contribution in
this area by providing a method by which the government is able to
determine the effectiveness of their decontamination efforts in hours
rather than days."